Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-label, Multicenter, Non-comparative Pharmacokinetics and Safety Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Conditions
Interventions
isavuconazonium sulfate - intravenous
isavuconazonium sulfate - oral
Locations
16
United States
Miller Children's Hospital
Long Beach, California, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
CHOC Children's Hospital of Orange County
Orange, California, United States
Nicklaus Children's Hospital
Miami, Florida, United States
Emory University School of Medicine
Atlanta, Georgia, United States
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Start Date
October 2, 2017
Primary Completion Date
July 5, 2019
Completion Date
July 5, 2019
Last Updated
November 19, 2024
NCT05537896
NCT04841447
NCT06106360
NCT02534649
NCT03159702
NCT07145359
Lead Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions